PDCD1 and melanoma: Furthermore, in a cohort of pre-PD-1 treated melanoma biopsies we found an association between the ‘MITF-low’ microRNAs, miR-100-5p and miR-125b-5p, with clinical benefit from PD-1 checkpoint blockade.